JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

The Journal of Nuclear Medicine Vol. 30 No. 12 2049-2052
© 1989 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ohta, H.
Right arrow Articles by Kotoura, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ohta, H.
Right arrow Articles by Kotoura, H.

Technetium-99m (V) DMSA Uptake in Amyloidosis

Hitoya Ohta, Keigo Endo, Tadashi Kanoh, Junji Konishi and Hajime Kotoura

Department of Nuclear Medicine, and Internal Medicine, Kyoto University School of Medicine, and Wakayama Red Cross Hospital, Kyoto, Japan

Correspondence: For reprints contact: Keigo Endo 075-751-3761 (JAPAN), Dept. of Nuclear Medicine, Kyoto University Hospital, 54 ShogoinKawaharacho, Sakyoku, Kyoto 606 Japan.

ABSTRACT

Technetium-99m(V) DMSA scintigraphy was performed in two patients with pathologically confirmed amyloidosis associated with plasmacytoma. Significant uptake of the tracer was found in the deposition of amyloid. Technetium-99m(V) DMSA scintigraphy could be useful in determining the appropriate region of biopsy and in forecasting the prognosis of patient with plasmacytoma.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1989 by the Society of Nuclear Medicine.